scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1011719295 |
P356 | DOI | 10.1381/096089206776944940 |
P698 | PubMed publication ID | 16687021 |
P5875 | ResearchGate publication ID | 7094287 |
P50 | author | Spiros T Papavramidis | Q118869213 |
P2093 | author name string | George Koliakos | |
Efstathios V Kotidis | |||
Theodosios S Papavramidis | |||
P433 | issue | 5 | |
P921 | main subject | gastrectomy | Q827390 |
P304 | page(s) | 554-559 | |
P577 | publication date | 2006-05-01 | |
P1433 | published in | Obesity Surgery | Q15762541 |
P1476 | title | The effect of biliopancreatic diversion with pylorus-preserving sleeve gastrectomy and duodenal switch on fasting serum ghrelin, leptin and adiponectin levels: is there a hormonal contribution to the weight-reducing effect of this procedure? | |
P478 | volume | 16 |
Q38016548 | A systematic review of the impact of weight loss on cancer incidence and mortality. |
Q37995497 | Bariatric surgery evolution from the malabsorptive to the hormonal era. |
Q57145864 | Bone Health After Bariatric Surgery |
Q37812028 | Changes in Ghrelin Levels Following Bariatric Surgery: Review of the Literature |
Q30391329 | Changes in neurohormonal gut peptides following bariatric surgery |
Q34589770 | Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion? |
Q43241597 | Early postoperative insulin-resistance changes after sleeve gastrectomy |
Q51359915 | Effect of Roux-en-Y gastric bypass vs sleeve gastrectomy on glucose and gut hormones: a prospective randomised trial. |
Q47296414 | Effect of marked weight loss on adiponectin gene expression and plasma concentrations. |
Q43217775 | Effects of two variants of Roux-en-Y Gastric bypass on metabolism behaviour: focus on plasma ghrelin concentrations over a 2-year follow-up |
Q37460873 | Expert panel on weight loss surgery: executive report update |
Q47198263 | Ghrelin and apolipoprotein AIV levels show opposite trends to leptin levels during weight loss in morbidly obese patients. |
Q35056692 | Ghrelin and hypothalamic development: too little and too much of a good thing |
Q34026487 | Ghrelin and metabolic surgery |
Q48238552 | Glucagon-Like Peptides 1 and 2 Are Involved in Satiety Modulation After Modified Biliopancreatic Diversion: Results of a Pilot Study |
Q53171656 | Indications and Operative Outcomes of Gastric Bypass Reversal. |
Q37080995 | Indications for sleeve gastrectomy as a primary procedure for weight loss in the morbidly obese |
Q33669032 | Laparoscopic Sleeve Gastrectomy—Radiological Assessment of Fundus Size and Sleeve Voiding |
Q43122009 | Laparoscopic sleeve gastrectomy for morbid obesity. |
Q81345083 | Laparoscopic sleeve gastrectomy in ethnic obese Chinese |
Q47398463 | Laparoscopic sleeve gastrectomy with minimal morbidity. Early results in 120 morbidly obese patients |
Q51692181 | Laparoscopic sleeve gastrectomy without an over-sewing of the staple line. |
Q37922651 | Metabolic surgery-principles and current concepts |
Q92068508 | Micronutrient management following bariatric surgery: the role of the dietitian in the postoperative period |
Q34978864 | Molecular insights from bariatric surgery |
Q37000435 | Pathophysiology of obesity: why surgery remains the most effective treatment |
Q51439550 | Plasma ghrelin modulation in gastric band operation and sleeve gastrectomy. |
Q38072445 | Risk of completed suicide after bariatric surgery: a systematic review |
Q37862878 | Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. |
Q33361316 | Sleeve gastrectomy relieves steatohepatitis in high-fat-diet-induced obese rats |
Q81712101 | Sleeve gastrectomy-a "food limiting" operation |
Q57122776 | Surgical treatment of nonseverely obese patients with type 2 diabetes mellitus: sleeve gastrectomy with ileal transposition (SGIT) is the same as the neuroendocrine brake (NEB) procedure or ileal interposition associated with sleeve gastrectomy (II-S |
Q50189034 | Technical aspects of laparoscopic sleeve gastrectomy in 25 morbidly obese patients |
Q37115509 | The First International Consensus Summit for Sleeve Gastrectomy (SG), New York City, October 25-27, 2007. |
Q42730636 | The Impact of Ghrelin in Metabolic Diseases: An Immune Perspective |
Q30388925 | The neurohormonal regulation of energy intake in relation to bariatric surgery for obesity |
Q47390443 | Weight loss and changes in salivary ghrelin and adiponectin: comparison between sleeve gastrectomy and Roux-en-Y gastric bypass and gastric banding |
Search more.